Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 19, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

[Liver chemoembolization: an update].

Alain Roche1

  • 1Département d'imagerie, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94800 Villejuif, France. alain.roche@igr.fr

Bulletin Du Cancer
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of single-dose injectable paracetamolversus propacetamol in pain management after minor gynecologic surgery: A multicenter, randomized, double-blind, active-controlled, two-parallel-group study.

Current therapeutic research, clinical and experimental·2014
Same author

Estimation of intra-operator variability in perfusion parameter measurements using DCE-US.

World journal of radiology·2011
Same author

Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.

Discovery medicine·2011
Same author

Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.

Radiology·2010
Same author

Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Investigational new drugs·2010
Same author

Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment.

Targeted oncology·2010

New percutaneous intraarterial liver tumor treatments, including microsphere chemotherapy and yttrium 90, are expanding treatment options. These advanced techniques show promise for hepatocellular carcinoma and neuroendocrine tumor metastasis.

Area of Science:

  • Interventional Radiology
  • Oncology
  • Hepatobiliary Medicine

Background:

  • Percutaneous intraarterial therapies for liver tumors are evolving rapidly.
  • Established chemoembolization techniques are effective for specific liver pathologies.

Purpose of the Study:

  • To review emerging percutaneous intraarterial treatment methods for liver tumors.
  • To highlight the expanding indications and established roles of chemoembolization.

Main Methods:

  • Review of novel therapeutic agents, including microsphere-encapsulated chemotherapy and yttrium 90 microspheres.
  • Analysis of current clinical applications and ongoing evaluations of these techniques.
  • Synthesis of evidence from controlled studies and meta-analyses on chemoembolization.

More Related Videos

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Related Experiment Videos

Last Updated: Jun 19, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Main Results:

  • New methods are expanding treatment indications, notably for colorectal cancer metastasis.
  • Hepatocellular carcinoma and neuroendocrine tumor metastasis respond well to conventional chemoembolization.
  • Controlled studies confirm established curative, palliative, and adjuvant roles for chemoembolization in hepatocellular carcinoma.

Conclusions:

  • Percutaneous intraarterial techniques offer continuously developing treatment options for liver tumors.
  • Advanced therapies broaden the scope of treatment for various liver malignancies.
  • Chemoembolization is a well-established treatment modality for hepatocellular carcinoma.